Reported 4 days ago
Starting January 1, 2025, pharmaceutical companies plan to increase prices on at least 250 branded medications, including COVID-19 treatments and cancer therapies. Most price hikes will be under 10%, with a median increase of 4.5%. While some companies, like Merck, are reducing prices for certain drugs, the overall trend reflects a pattern of rising costs for U.S. prescription medications, which are among the highest in the world.
Source: YAHOO